Top Menu

FCPA Flash – A Conversation With Robert Luskin Regarding FCPA Enforcement Actions Against Foreign Companies

Podcast Logo

The FCPA Flash podcast provides in an audio format the same fresh, candid, and informed commentary about the Foreign Corrupt Practices Act and related topics as readers have come to expect from written posts on FCPA Professor.

This FCPA Flash episode is a conversation with Robert Luskin (Paul Hastings). Luskin has a wealth of experience representing foreign companies (including Technip, Total, Alstom and SBM Offshore) in FCPA enforcement actions. During the podcast, Luskin: (i) elaborates on his previous comments that foreign corporations in FCPA inquiries have real concerns about “whether U.S. lawyers are really defense lawyers or former prosecutors in a better suit” and how some FCPA practitioners are not willing to be adverse to the DOJ; (ii) discusses legal and policy issues present in FCPA enforcement actions against foreign companies; and (iii) opines whether the FCPA has been successful in achieving its objectives including whether any reform is desirable.

Continue Reading

FCPA Flash – A Conversation With David Pere Regarding Developments In France

Podcast Logo

The FCPA Flash podcast provides in an audio format the same fresh, candid, and informed commentary about the Foreign Corrupt Practices Act and related topics as readers have come to expect from written posts on FCPA Professor.

This FCPA Flash episode is a conversation with David Pere (an attorney in the Paris office of Bryan Cave). During the podcast, Pere discusses: (i) developments in France relevant to the anti-bribery and compliance space including, most notably, the new so-called Sapin II law and the new French anti-corruption agency (AFA); (ii) what general counsel and other compliance professionals need to know about the new law and enforcement agency; and (iii) French resentment to aggressive U.S. prosecution of French companies based on sparse jurisdictional allegations.

Continue Reading

Next Up – Telia As DOJ And SEC Announce Contemplated $483 Million Net FCPA Enforcement Action

telia

This recent post asked: what will September bring and noted that with history as a guide likely notable FCPA enforcement actions.

This 2015 post highlighted the burgeoning Uzbekistan telecommunication investigations involving Dutch telecom company VimpleCom, Swedish telecom company TeliaSonera, and Russia-based Mobile TeleSystems.

As highlighted here, in February 2016 VimpelCom resolved a net $397.5 million FCPA enforcement action and as highlighted below yesterday the DOJ and SEC announced a contemplated $483 million net FCPA enforcement against against Telia (after accounting for various credits and deductions for contemplated Swedish and Dutch enforcement actions) – the 5th largest net FCPA settlement of all-time.

Continue Reading

U.S. Government Reportedly Investigating Chinese Government For Bribery In Nigeria

sinopec

Regarding the above headline, technically, as noted in this Bloomberg report, the DOJ and SEC are investigating China Petroleum & Chemical Corporation (Sinopec – a Chinese state-owned entity) with shares traded on a U.S. exchange for bribery in Nigeria.

However, given that the DOJ and SEC consider certain state-owned entities like Sinopec to be “instrumentalities” of a foreign government, the above headline is accurate.

This previous post highlighted how there has never been an FCPA enforcement against a Chinese-based issuer, but this is likely just a matter of time as the previous post noted that Sinovac Biotech [a Beijing based company with shares traded on NASDAQ] is currently under FCPA scrutiny.

Add Sinopec to the list.

Continue Reading

Might Sinovac Become The First Chinese Issuer To Resolve An FCPA Enforcement Action?

sinovac

A long, long time ago (September 2009 to be exact) FCPA Professor highlighted how Chinese companies were increasingly seeking to raise capital in the U.S. and by registering securities in the U.S. becoming subject to a variety of U.S. laws including the Foreign Corrupt Practices Act.

There has never been an FCPA enforcement against a Chinese-based issuer, but that could change.

This post highlights the FCPA scrutiny of Beijing-based Sinovac Biotech, a company with shares traded on NASDAQ, including its recent disclosure that it is unable to file its annual report because of a bribery internal investigation.

Continue Reading

Powered by WordPress. Designed by WooThemes